Journal article
XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration
Abstract
IntroductionXTEND (NCT03939767) is a multicenter, observational, prospective study of patients with treatment-naïve neovascular age-related macular degeneration (nAMD) in routine clinical practice. The study aims to examine treatment outcomes of proactive intravitreal aflibercept (IVT-AFL) treatment regimens (fixed dosing or treat-and-extend) according to local marketing labels.MethodsStudy eyes received IVT-AFL injections as per the local …
Authors
Korobelnik J-F; Chaudhary V; Mitchell P; Kang SW; Tadayoni R; Allmeier H; Lee J; Zhang X; Machewitz T; Bailey C
Journal
Ophthalmology and Therapy, Vol. 13, No. 3, pp. 725–738
Publisher
Springer Nature
Publication Date
3 2024
DOI
10.1007/s40123-023-00867-x
ISSN
2193-8245